The continuing success of the combinatorial approach is heavily reliant on
analytical methodologies, which allow for the rapid and accurate characteri
sation of medicinally relevant molecules from compound libraries. Mass spec
trometry has recently been touted as the most suitable tool for a range of
combinatorial applications such as structural elucidation and screening. Th
e refinement of conventional methods, developments of techniques such as Fo
urier transform ion cyclotron resonance and new screening methodologies hav
e allowed the medicinal chemist to tackle the growing analytical challenges
posed by combinatorial chemistry.